Ergonomic chair statistics are best interpreted through the work settings, pain burden and intervention studies surrounding chair use. The available evidence does not provide a direct population count of ergonomic-chair ownership, purchases or market revenue, so work and health measures below are explicitly treated as context rather than adoption totals.
Key Ergonomic Chair Statistics
The most useful figures span employment, work location, musculoskeletal conditions, pain and measured workplace interventions:
- In the United States, 167.443 million people aged 15 and over were employed in 2025.
- In the United States, 109.667 million employed people worked on an average day in 2025, equal to 65.5% of employed people aged 15 and over.
- 70.0% of U.S. full-time workers worked on an average day in 2025, compared with 48.1% of part-time workers.
- 32.045 million U.S. workers were in management, business and financial operations occupations in 2025.
- 17.356 million U.S. workers were in office and administrative-support occupations in 2025.
- U.S. employed people who worked on an average day worked 7.66 hours on average in 2025.
- Among U.S. employed people who worked, 69.8% worked at a workplace and 34.5% worked at home in 2025.
- In 2019, 1.71 billion people worldwide lived with a musculoskeletal condition, according to the WHO summary of GBD 2019 estimates.
- Musculoskeletal conditions represented about 17% of all global years lived with disability in GBD 2019 estimates.
- Low back pain affected approximately 570 million people worldwide in 2019 in GBD estimates.
- In the 2019 U.S. NHIS, 39.0% of adults aged 18 and over experienced back pain during the prior three months.
- In the 2019 U.S. NHIS, 36.5% of U.S. adults experienced hip, knee or foot pain during the prior three months.
- In the 2019 U.S. NHIS, 30.7% of U.S. adults experienced hand, arm or shoulder pain during the prior three months.
- An estimated 543,000 workers in Great Britain had a new or long-standing work-related MSD in 2023/24.
- Work-related MSDs caused 7.8 million working days lost in Great Britain in 2023/24.
- Great Britain’s estimated workplace injury and new work-related ill-health cost was £21.6 billion for 2022/23, in 2023 prices.
- In a Malaysian office-worker trial, neck MSD percentage fell by 42.2% at six-month follow-up, with a 95% confidence interval of 24.4% to 60.0%.
Contents
- How many people work in chair-intensive settings?
- Where people work and how long: office, home and hybrid data
- Global musculoskeletal-condition statistics
- U.S. adult back, lower-limb and upper-limb pain
- Work-related MSDs, lost time and economic costs
- What office-worker ergonomic interventions measured
How Many People Work in Chair-Intensive Settings?
The U.S. Bureau of Labor Statistics does not identify chair use directly in these tables. Its employment and occupation figures therefore indicate the scale of potentially chair-intensive work without measuring ergonomic-chair ownership or continuous sitting.
| U.S. employment context | 2025 annual average |
|---|---|
| Civilian employed population, age 15+ | 167.443 million |
| Employed people working on an average day | 109.667 million (65.5%) |
| Full-time workers working on an average day | 70.0% |
| Part-time workers working on an average day | 48.1% |
Source: BLS Table 6, 2025 annual averages. ATUS measures time use and whether work occurred, not sitting or chair ownership.
Occupation groups offer another broad proxy. Management, business and financial operations included 32.045 million employed people; office and administrative-support occupations included 17.356 million; and professional and related occupations included 44.354 million in the 2025 annual average.
These groups are not synonymous with seated work. They contain varied tasks, so their counts should not be presented as ergonomic-chair users.
Source: BLS Table 7, 2025 annual averages.
Where People Work and How Long: Office, Home and Hybrid Data
Work location matters because a chair may be supplied by an employer, selected for a home workstation, or used across both settings. The 2025 American Time Use Survey allows overlapping location categories: a person can work at a workplace and at home on the same day.
| Measure | U.S. 2025 annual average |
|---|---|
| Average work time among people who worked | 7.66 hours per day |
| Worked at a workplace | 69.8% |
| Worked at home | 34.5% |
| Average time at workplace among those working there | 7.87 hours |
| Average time at home among those working there | 5.10 hours |
Source: BLS Table 6. These are work-time measures, not continuous sitting or ergonomic exposure durations.
Full-time workers who worked averaged 8.07 hours, compared with 5.36 hours for part-time workers. The same table reports home-work shares of 31.3% for men and 38.2% for women, while multiple jobholders were at 41.2% compared with 33.7% for single jobholders.
Among workers aged 25 and over, 51.4% of those with a bachelor’s degree or higher worked at home, compared with 9.1% of those with less than a high-school diploma. Education groups describe work location and do not measure chair access or quality.
Occupation-specific hours show why broad averages need careful interpretation:
- Management, business and financial operations workers averaged 7.84 hours at a workplace and 5.64 hours at home on days worked.
- Office and administrative-support workers averaged 7.90 hours at a workplace and 6.02 hours at home on days worked.
Source: BLS Table 7. Workplace and home hours are not mutually exclusive, and the occupation categories remain proxies rather than direct sitting measures.
Global Musculoskeletal-Condition Statistics and Low Back Pain Data
The WHO’s summary of Global Burden of Disease 2019 estimates places ergonomic-chair discussions within a much larger health burden. These figures cover more than office workers and do not establish that chairs or sitting caused the conditions.
| Global measure | GBD 2019 estimate |
|---|---|
| People living with a musculoskeletal condition | Approximately 1.71 billion |
| Years lived with disability from musculoskeletal conditions | Approximately 149 million |
| Share of all global YLDs | About 17% |
| Prevalent low-back-pain cases | Approximately 570 million |
| Global YLD share attributed to low back pain | About 7.4% |
| People affected by osteoarthritis | Approximately 528 million |
| People affected by neck pain | Approximately 222 million |
Source: WHO Musculoskeletal health. YLDs aggregate disability across more than 150 conditions, and low back pain has multiple causes.
The WHO regional summary estimated approximately 441 million people living with musculoskeletal conditions in its high-income-country grouping, 427 million in the Western Pacific Region and 369 million in the South-East Asia Region. These are regional counts, not prevalence rates and not chair-market sizes.
U.S. Adult Back, Lower-Limb and Upper-Limb Pain Statistics
The 2019 National Health Interview Survey measured self-reported pain among civilian noninstitutionalized U.S. adults aged 18 and over during the prior three months. It did not attribute pain to sitting, chairs, computer work or any other ergonomic exposure.
| Pain location | U.S. adults reporting pain, 2019 |
|---|---|
| Any measured location | 58.9% |
| Back | 39.0% |
| Hip, knee or foot | 36.5% |
| Hand, arm or shoulder | 30.7% |
Source: NCHS Data Brief No. 415.
Back-pain prevalence was 28.4% among adults aged 18–29 and 45.6% among those aged 65 and over. It was 40.6% for women and 37.2% for men, 42.7% among non-Hispanic White adults and 24.5% among non-Hispanic Asian adults, and 44.8% among adults below 100% of the federal poverty level compared with 37.6% among adults at 200% or more of that level.
Lower-limb pain ranged from 21.0% among adults aged 18–29 to 50.3% among those aged 65 and over. The corresponding estimates were 40.1% among non-Hispanic White adults and 20.6% among non-Hispanic Asian adults.
Upper-limb pain ranged from 16.2% among adults aged 18–29 to 42.0% among those aged 65 and over. It was 33.4% among non-Hispanic White adults and 21.0% among non-Hispanic Asian adults.
These subgroup results are descriptive, self-reported estimates. They identify the scale and distribution of pain, not a causal effect of ergonomic chairs.
Work-Related MSDs, Lost Time and Economic Costs
Great Britain’s Health and Safety Executive provides work-related measures from Labour Force Survey self-reports for 2023/24. The data cover people who worked in the last 12 months and are not chair-specific clinical diagnoses.
| Great Britain measure | 2023/24 estimate |
|---|---|
| New or long-standing work-related MSD | 543,000 workers |
| New work-related MSD | 168,000 workers |
| Working days lost to work-related MSDs | 7.8 million days |
| Cases affecting the back | 43%, about 232,000 workers |
| Cases affecting upper limbs or neck | 37%, about 203,000 workers |
| Cases affecting lower limbs | 20%, about 108,000 workers |
Source: HSE Health and safety at work: Summary statistics for Great Britain 2024. HSE rounded component shares and counts.
The HSE estimated the annual cost of workplace injury and new work-related ill health in Great Britain at £21.6 billion for 2022/23, stated in 2023 prices. The HSE Cost Model includes financial and human costs, excludes long-latency illness such as cancer, and uses a three-year rolling basis.
Of that estimate, £4.1 billion was borne by employers, £4.9 billion by government and £12.6 billion by individuals. These are costs associated with workplace injury and new work-related ill health, not the cost of ergonomic chairs or a measured return on chair investment.
What Office-Worker Ergonomic Interventions Measured
Trials provide more direct evidence about ergonomic programs, but the supplied studies do not isolate a chair-only effect. One Malaysian trial combined ergonomics training and workstation practice, while the Finnish trial involved workers with ongoing or recurrent low-back pain and compared a participatory intervention with standard occupational-physiotherapist counselling and guidance.
In the Malaysian office-worker trial, the largest reduction in musculoskeletal-disorder percentage was in the neck region: 42.2% at six-month follow-up, with a 95% confidence interval from 24.4% to 60.0%. Before training, the sample reported 51.6% 12-month shoulder MSD prevalence, 48.2% neck MSD prevalence and 42.2% back MSD prevalence.
Source: Ergonomic Training Reduces Musculoskeletal Disorders among Office Workers. The finding is a multi-component intervention result, not a chair-only causal estimate.
The Finnish randomized workplace trial describes its participants rather than all office workers. Women represented 74% of recruited workers, and 49% of the intervention group versus 45% of the control group described their workload as strenuous.
At baseline, self-assessed work-productivity loss was 27.9% in the intervention group and 23.0% in the control group. The comparison group received standard occupational-physiotherapist counselling and guidance, so these figures are trial-population outcomes rather than estimates of general ergonomic-chair adoption or universal productivity effects.
Source: Participatory Ergonomics Intervention to Prevent Work Disability Among Workers with Low Back Pain. Trial results are setting-specific, and no personal medical advice is implied.